P-glycoprotein and alloimmune T-cell activation

Clinical and Applied Immunology Reviews

Volumn 4, Issue 1, 2003, Pages 3-14

  Pendse, Shona S ^a,b   Briscoe, David M ^b   Frank, Markus H ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Antigen presentation; P glycoprotein; T cell activation

Indexed keywords

ABC TRANSPORTER; CYTOKINE; GENE PRODUCT; GLYCOPROTEIN P; MULTIDRUG RESISTANCE PROTEIN;

ALLOIMMUNITY; ANTIGEN PRESENTING CELL; CELL DIFFERENTIATION; CELL SECRETION; CELL SURVIVAL; CELLULAR IMMUNITY; GRAFT REJECTION; HUMAN; IMMUNE RESPONSE; MONONUCLEAR CELL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; T LYMPHOCYTE ACTIVATION; TRANSPLANTATION;

EID: 0037971930     PISSN: 15291049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1529-1049(03)00007-2     Document Type: Article

References (47)

1. Klein I. Sarkadi B. Varadi A. An inventory of the human ABC proteins Biochim Biophys Acta 1461 1999 237-262
2. van Asperen J. Schinkel A.H. Beijnen J.H. Nooijen W.J. Borst P. van Tellingen O. Altered pharmacokinetics of vinblastine in Mdr1a P-glycoprotein- deficient Mice J Natl Cancer Inst 88 1996 994-999
3. Gottesman M.M. Pastan I. Biochemistry of multidrug resistance mediated by the multidrug transporter Annu Rev Biochem 62 1993 385-427
4. Ford J.M. Experimental reversal of P-glycoprotein-mediated multidrug resistance by pharmacological chemosensitisers Eur J Cancer 32A 1996 991-1001
5. Ford J.M. Hait W.N. Pharmacology of drugs that alter multidrug resistance in cancer Pharmacol Rev 42 1990 155-199
6. Smith A.J. Mayer U. Schinkel A.H. Borst P. Availability of PSC833, a substrate and inhibitor of P-glycoproteins, in various concentrations of serum J Natl Cancer Inst 90 1998 1161-1166
7. Mayer U. Wagenaar E. Dorobek B. Beijnen J.H. Borst P. Schinkel A.H. Full blockade of intestinal P-glycoprotein and extensive inhibition of blood-brain barrier P-glycoprotein by oral treatment of mice with PSC833 J Clin Invest 100 1997 2430-2436
8. Okochi E. Iwahashi T. Tsuruo T. Monoclonal antibodies specific for P-glycoprotein Leukemia 11 1997 1119-1123
9. Volm M. Multidrug resistance and its reversal Anticancer Res 18 1998 2905-2917
10. Wang L. Chen L. Walker V. Jacob T.J. Antisense to MDR1 mRNA reduces P-glycoprotein expression, swelling- activated C1- current and volume regulation in bovine ciliary epithelial cells J Physiol 511 1998 33-44
11. de Vree J.M. Jacquemin E. Sturm E. Cresteil D. Bosma P.J. Aten J. et al Mutations in the MDR3 gene cause progressive familial intrahepatic cholestasis Proc Natl Acad Sci USA 95 1998 282-287
12. Fojo A.T. Ueda K. Slamon D.J. Poplack D.G. Gottesman M.M. Pastan I. Expression of a multidrug-resistance gene in human tumors and tissues Proc Natl Acad Sci USA 84 1987 265-269
13. Ernest S. Bello-Reuss E. P-glycoprotein functions and substrates: possible roles of MDR1 gene in the kidney Kidney Int Suppl 65 1998 S11-S17
14. Johnstone R.W. Ruefli A.A. Smyth M.J. Multiple physiological functions for multidrug transporter P- glycoprotein? Trends Biochem Sci 25 2000 1-6
15. Neyfakh A.A. Serpinskaya A.S. Chervonsky A.V. Apasov S.G. Kazarov A.R. Multidrug-resistance phenotype of a subpopulation of T-lymphocytes without drug selection Exp Cell Res 185 1989 496-505
16. Chaudhary P.M. Roninson I.B. Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cells Cell 66 1991 85-94
17. Chaudhary P.M. Mechetner E.B. Roninson I.B. Expression and activity of the multidrug resistance P-glycoprotein in human peripheral blood lymphocytes Blood 80 1992 2735-2739
18. Coon J.S. Wang Y.Z. Bines S.D. Markham P.N. Chong A.S. Gebel H.M. Multidrug resistance activity in human lymphocytes Hum Immunol 32 1991 134-140
19. Drach D. Zhao S. Drach J. Mahadevia R. Gattringer C. Huber H. et al Subpopulations of normal peripheral blood and bone marrow cells express a functional multidrug resistant phenotype Blood 80 1992 2729-2734
20. Drach J. Zhao S. Drach D. Korbling M. Engel H. Andreeff M. Expression of MDR1 by normal bone marrow cells and its implication for leukemic hematopoiesis Leuk Lymphoma 16 1995 419-424
21. Auchincloss H.Jr. Lee R. Shea S. Markowitz J.S. Grusby M.J. Glimcher L.H. The role of "indirect" recognition in initiating rejection of skin grafts from major histocompatibility complex class II-deficient mice Proc Natl Acad Sci USA 90 1993 3373-3377
22. Sayegh M.H. Why do we reject a graft? Role of indirect allorecognition in graft rejection Kidney Int 56 1999 1967-1979
23. van der Heyden S. Gheuens E. DeBruijn E. Van Oosterom A. Maes R. P-glycoprotein: clinical significance and methods of analysis Crit Rev Clin Lab Sci 32 1995 221-264
24. Neyfakh A.A. Dmitrevskaya T.V. Serpinskaya A.S. The membrane transport system responsible for multidrug resistance is operating in nonresistant cells Exp Cell Res 178 1988 513-517
25. Kartner N. Evernden-Porelle D. Bradley G. Ling V. Detection of P-glycoprotein in multidrug-resistant cell lines by monoclonal antibodies Nature 316 1985 820-823
26. Hamada H. Tsuruo T. Functional role for the 170- to 180-kDa glycoprotein specific to drug- resistant tumor cells as revealed by monoclonal antibodies Proc Natl Acad Sci USA 83 1986 7785-7789
27. Meyers M.B. Rittmann-Grauer L. O'Brien J.P. Safa A.R. Characterization of monoclonal antibodies recognizing a Mr 180,000 P- glycoprotein: differential expression of the Mr 180,000 and Mr 170,000 P-glycoproteins in multidrug-resistant human tumor cells Cancer Res 49 1989 3209-3214
28. Pearson J.W. Fogler W.E. Volker K. Usui N. Goldenberg S.K. Gruys E. et al Reversal of drug resistance in a human colon cancer xenograft expressing MDR1 complementary DNA by in vivo administration of MRK-16 monoclonal antibody J Natl Cancer Inst 83 1991 1386-1391
29. Arceci R.J. Stieglitz K. Bras J. Schinkel A. Baas F. Croop J. Monoclonal antibody to an external epitope of the human mdr1 P- glycoprotein Cancer Res 53 1993 310-317
30. Klimecki W.T. Futscher B.W. Grogan T.M. Dalton W.S. P-glycoprotein expression and function in circulating blood cells from normal volunteers Blood 83 1994 2451-2458
31. Frank M. Denton M. Alexander S. Khoury S. Sayegh M. Briscoe D. Specific MDR1 P-glycoprotein blockade inhibits human alloimmune T cell activation in vitro J Immunol 166 2001 2451-2459
32. Schinkel A.H. Roelofs E.M. Borst P. Characterization of the human MDR3 P-glycoprotein and its recognition by P-glycoprotein-specific monoclonal antibodies Cancer Res 51 1991 2628-2635
33. + T cells: a role in cytotoxic effector function J Clin Immunol 12 1992 451-458
34. Mu X.Y. Gosland M.P. Bartik M.M. Schimmelpfennig J. Kay N.E. Activation of human peripheral blood T cells does not lead to increased P-glycoprotein expression J Clin Immunol 19 1999 239-246
35. Drach J. Gsur A. Hamilton G. Zhao S. Angerler J. Fiegl M. et al Involvement of P-glycoprotein in the transmembrane transport of interleukin-2 (IL-2), IL-4, and interferon-gamma in normal human T lymphocytes Blood 88 1996 1747-1754
36. Raghu G. Park S.W. Roninson I.B. Mechetner E.B. Monoclonal antibodies against P-glycoprotein, an MDR1 gene product, inhibit interleukin-2 release from PHA-activated lymphocytes Exp Hematol 24 1996 1258-1264
37. Gollapudi S. Kim C. Gupta S. P-glycoprotein (encoded by multidrug resistance genes) is not required for interleukin-2 secretion in mice and humans Genes Immun 1 2000 371-379
38. Johnstone R.W. Cretney E. Smyth M.J. P-glycoprotein protects leukemia cells against caspase-dependent, but not caspase-independent, cell death Blood 93 1999 1075-1085
39. Johnstone R.W. Ruefli A.A. Tainton K.M. Smyth M.J. A role for P-glycoprotein in regulating cell death Leuk Lymphoma 38 2000 1-11
40. Tainton K.M. Ruefli A.A. Smyth M.J. Johnstone R.W. Equivalent death of P-glycoprotein expressing and nonexpressing cells induced by the protein kinase C inhibitor staurosporine Biochem Biophys Res Commun 276 2000 231-237
41. Bommhardt U. Cerottini J.C. MacDonald H.R. Heterogeneity in P-glycoprotein (multidrug resistance) activity among murine peripheral T cells: correlation with surface phenotype and effector function Eur J Immunol 24 1994 2974-2981
42. Eisenbraun M.D. Miller R.A. mdr1a-encoded P-glycoprotein is not required for peripheral T cell proliferation, cytokine release, or cytotoxic effector function in mice J Immunol 163 1999 2621-2627
43. Gupta S. Gollapudi S. P-glycoprotein (MDR 1 gene product) in cells of the immune system: its possible physiologic role and alteration in aging and human immunodeficiency virus-1 (HIV-1) infection J Clin Immunol 13 1993 289-301
44. Randolph G.J. Beaulieu S. Pope M. Sugawara I. Hoffman L. Steinman R.M. et al A physiologic function for p-glycoprotein (MDR-1) during the migration of dendritic cells from skin via afferent lymphatic vessels Proc Natl Acad Sci USA 95 1998 6924-6929
45. Kemnitz J. Uysal A. Haverich A. Heublein B. Cohnert T.R. Stangel W. et al Multidrug resistance in heart transplant patients: a preliminary communication on a possible mechanism of therapy-resistant rejection J Heart Lung Transplant 10 1991 201-210
46. Yousem S.A. Sartori D. Sonmez-Alpan E. Multidrug resistance in lung allograft recipients: possible correlation with the development of acute and chronic rejection J Heart Lung Transplant 12 1993 20-26
47. Kobayashi Y. Yamashiro T. Nagatake H. Yamamoto T. Watanabe N. Tanaka H. et al Expression and function of multidrug resistance P-glycoprotein in a cultured natural killer cell-rich population revealed by MRK16 monoclonal antibody and AHC-52 Biochem Pharmacol 48 1994 1641-1646